Psychedelics Today
In this episode, we sit down with ., to discuss why the future of psychedelic access in the United States is being shaped not by federal agencies, but by the bold actions of individual states. As a legal scholar and writer focusing on drug policy, Victoria breaks down the significance of the FDA’s 2024 rejection of psychedelic-assisted therapy, and why that decision might be less of a setback than it seems. We explore how state-level initiatives like Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are setting the stage for a new model of access—one rooted...
info_outlinePsychedelics Today
info_outlinePsychedelics Today
info_outlinePsychedelics Today
Joe Moore and Anne Philippi are hosts of the PS25 Morning Show! This one features Dee Dee Goldpaugh, LCSW and Tommaso Barba, PhDC! We talk about all things Sex and Psychedelics!
info_outlinePsychedelics Today
n this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences – one of the world’s leading ibogaine clinics – to explore the potential of ibogaine for addiction, neuroregeneration, and how ethics, honoring experience, and sustainability will be key to delivering ibogaine at scale. Trevor shares his early work supporting marginalized populations in Vancouver’s Downtown Eastside, which led to the founding of Liberty Root, one...
info_outlinePsychedelics Today
In this episode of Psychedelics Today, hosts sit down with Jeff Breau from Harvard Divinity School's Center for the Study of World Religions. Key themes include the intersection of psychedelics and religion, harm reduction practices, and the burgeoning psychedelic church movement. Jeff brings insights from his ethnographic research on psychedelic churches and discusses the importance of interdisciplinary collaboration for advancing understanding in this field. He also delves into the role of music in psychedelic therapy, critiques of the Mystical Experience Questionnaire (MEQ), and the...
info_outlinePsychedelics Today
In this episode, Joe Moore sits down with from to discuss a range of fascinating topics. They begin by discussing the Harvard Divinity School and the CSWR’s mission and history. The conversation delves into the work and legacy of , a pivotal figure in the 1960s psychedelic harm reduction movement. It explores her contributions to the field through her Psychedelic Information Center. They also touch on the Quaker traditions and their intersection with LSD use, showing how spirituality and psychedelics can coalesce. Paul also talks about upcoming psychedelic and chaplaincy workshops,...
info_outlinePsychedelics Today
In this episode of Psychedelics Today, Joe Moore speaks with Dr. Simon Ruffell, a London-based psychiatrist, researcher, and curandero-in-training in the López Mahua lineage of the Shipibo tradition. Dr. Ruffell shares how his early fascination with psychiatry eventually led to a deep disillusionment with the limitations of conventional treatments—and a surprising pivot toward the Amazon. Now working at the intersection of Indigenous healing and clinical research, Ruffell describes his journey from medical school to shamanic apprenticeship. He offers insight into the Shipibo understanding...
info_outlinePsychedelics Today
Aspen Psychedelic Symposium 2024 – Hosted by Kevin Franciotti This powerful panel explores the healing potential and complex responsibilities that come with working with Ibogaine, a potent plant-based psychedelic. Moderator Kevin Franciotti guides a heartfelt and informative conversation with Talia Eisenberg, Tom Feegel, and Dr. Lola "Dr. O" Hoba, highlighting personal transformation, medical protocols, and the importance of honoring traditional knowledge. Personal Journeys with Ibogaine Talia Eisenberg shares her recovery from opioid addiction and the founding of BEOND Ibogaine, a medical...
info_outlinePsychedelics Today
A panel discussion with Jim Harris, Rachel Zoeller, DPT, David W. McMillan, Ph.D., and Manesh Girn, Ph.D. Recorded live at the Aspen Psychedelic Symposium In this riveting and deeply personal conversation, moderator Jim Harris is joined by three pioneers at the intersection of neuroscience, psychedelics, and disability: Dr. Rachel Zoeller (Doctor of Physical Therapy and spinal cord injury survivor), Dr. David McMillan (Assistant Professor of Neurological Surgery at the University of Miami), and Dr. Manesh Girn (neuroscientist and postdoctoral researcher with Robin Carhart-Harris at UCSF)....
info_outlineIn today’s Solidarity Friday’s Episode with Kyle and Joe, they talk mostly about Corpora-delic, companies and wealthy individuals investing in the psychedelic industry.
Support the show
- Patreon
- Leave us a review on iTunes
- Share us with your friends – favorite podcast, etc
- Join our Facebook group - Psychedelics Today group – Find the others and create community.
Navigating Psychedelics
Show Notes
Psychedelics Company Orthogonal Thinker Closes $6M Seed Round
- The company is valued at 111 million
- The CEO, Jason Hobson says, “The current health pandemic has resulted in a societal shift in the way we think about our health and the importance of access to treatment, both physical health and mental health. Ei.Ventures believes this is the right time to lean into mental health issues such as mood disorders and addiction, and eventual access to therapeutic treatments from innovations in botanical compounds that have been around for thousands of years.”
- Joe and Kyle say that there is so much money coming in, and it worries the psychedelic community because they aren't used to seeing capitalism
- Joe says that he hopes that some patents don't equate to ruining access
Thiel Backs Psychedelic-Drug Startup in Latest Funding Round
- “Are these companies going to bully the smaller organizations out of existence so that diversity doesn't really exist in the way we think it should?” - Joe
- Medical is a great model, but it should be reduced to that only
- Kyle says the sacred-ness feels like it may be taken away, and big companies just look at it as a commodity
Medical Researchers Worry Silicon Valley Could Screw Up Psychedelics
- "Not everyone sees this opportunity for entrepreneurship as a good thing. For researchers looking into the efficacy of psychedelics for therapeutic purposes, these substances are far more than a market opportunity—they’re potentially life-saving medications. And after decades of prohibition, psychedelics are just barely gaining mainstream acceptance.’ - from the article
- People are bold enough to stand up to companies they don't agree with
It's no joke how much money was spent on making Tim Leary look bad
DARPA Wants Benefits of Psychedelics but Without Hallucinations
- The Defense Advanced Research Projects Agency (DARPA) is launching a new drug program for treating soldiers with PTSD, depression, anxiety, and drug addiction, and it is drawing inspiration from psychedelic research.
- Kyle mentions that this is tricky, its both a biochemical and experiential thing
- Will eliminating the hallucinations ruin the experience?
- Joe says that there are some people that are so unstable that a psychedelic experience can be really a lot
- Joe also says that there arent alot of drugs that their use needs to be supervised (medically) and psychedelics are some of them
How Climate Justice Could End the Drug War
- Joe recorded with Erica Darragh from Sunrise Movement
- Their talk was about how climate justice could end the drug war
- They talked about more equitable ways of including people of less power, influence or privilege into the world of psychedelics
- The more ahead we are of the government, the more likely we are to influence policy, Joe says it's best to just stay informed
A North Star for the Emerging Psychedelics Industry
- If we aren't coming from psychedelic values when bringing these substances into the mainstream, then what are we doing?
- What are psychedelic values?
- Valuing the planet, valuing your place in the planet, a sense of connection, cooperation vs. competition, how do we honor a lineage or where these medicines come from? these could be some psychedelic values
- Following the permaculture principles and applying them to life is a great tool for systems thinking
About Kyle
Kyle’s interest in exploring non-ordinary states of consciousness began when he was 16-years-old when he suffered a traumatic snowboarding accident. Waking up after having a near-death experience changed Kyle’s life. Since then, Kyle has earned his B.A. in Transpersonal Psychology, where he studied the healing potential of non-ordinary states of consciousness by exploring shamanism, plant medicine, Holotropic Breathwork, and the roots/benefits of psychedelic psychotherapy. Kyle has co-taught two college-level courses. One of the courses Kyle created as a capstone project, “Stanislav Grof’s Psychology of Extraordinary Experiences,” and the other one which he co-created, “The History of Psychedelics.”
Kyle completed his M.S. in clinical mental health counseling with an emphasis in somatic psychology. Kyle’s clinical background in mental health consists of working with at-risk teenagers in crisis and with individuals experiencing an early-episode of psychosis. Kyle also facilitates Transpersonal Breathwork workshops.
About Joe
Joe studied philosophy in New Hampshire, where he earned his B.A.. After stumbling upon the work of Stanislav Grof during his undergraduate years, Joe began participating in Holotropic Breathwork workshops in Vermont in 2003. Joe helped facilitate Holotropic and Transpersonal Breathwork workshops while he spent his time in New England. He is now working in the software industry as well as hosting a few podcasts. Joe now coordinates Dreamshadow Transpersonal Breathwork workshops, in Breckenridge, Colorado.
Get a 30 day free audible trial at audibletrial.com/psychedelicstoday